The Effect of Cysteine on Oxidation of Tyrosine, Dopa, and Cysteinyldopas

Overview

Journal Arch Dermatol Res

Specialty Dermatology

Date 1982 Jan 1

PMID 6819815

Citations 17

Authors

G AGRUP

C Hansson

H Rorsman

E ROSENGREN

Affiliations

Soon will be listed here.

Abstract

The influence of cysteine on the oxidation of tyrosine, dopa, and monocysteinyldopas by mushroom tyrosinase was reexamined. During oxidation of tyrosine in the presence of cysteine the concentration of dopa increased slowly, whereas the concentration of cysteinyldopas increased more rapidly. When the concentration of cysteine decreased the cysteinyldopas were rapidly consumed and dopa concentrations increased sharply. Experiments on the oxidation of dopa by tyrosinase in the presence of cysteine showed that this thiol does not inhibit the oxidation. Dopa concentrations decreased more rapidly in the presence of cysteine because cysteine addition to dopaquinone prevented reformation of dopa from dopaquinone. Both 2-S-cysteinyldopa and 5-S-cysteinyldopa are substrates for tyrosinase. The oxidation of cysteinyldopas was inhibited at high cysteine concentrations. The greater part of 2,5-S,S-dicysteinyldopa formed during the oxidation of monocysteinyldopas in the presence of cysteine is derived from 5-S-cysteinyldopa, which is a better substrate for tyrosinase than 2-S-cysteinyldopa. The fact that cysteine binds more rapidly to 5-S-cysteinyldopaquinone than to 2-S-cysteinyldopaquinone further stresses the importance of 5-S-cysteinyldopa in the formation of 2,5-S,S-dicysteinyldopa. Oxidation of dopa in the presence of cysteine and glutathione or methionine showed that glutathione is added to dopaquinone but less rapidly than cysteine. Methionine showed insignificant addition to dopaquinone. When dopa or 5-OH-dopa is added to an incubate of cysteinyldopa and tyrosinase the oxidation of cysteinyldopa is accelerated owing to oxidation of cysteinyldopa by dopaquinone or 5-OH-dopaquinone.

Citing Articles

The "Unconventional" Effect of Cysteine on the Synthesis of Melanin.

Vercruysse K ACS Omega. 2024; 9(21):22794-22800.

PMID: 38826551 PMC: 11137686. DOI: 10.1021/acsomega.4c00889.

Antioxidant mechanisms of mesenchymal stem cells and their therapeutic potential in vitiligo.

Yang R, Chen S, Fu S, Zhao D, Wan W, Yang K Front Cell Dev Biol. 2024; 11:1293101.

PMID: 38178870 PMC: 10764575. DOI: 10.3389/fcell.2023.1293101.

The mucin protein MUCL1 regulates melanogenesis and melanoma genes in a manner dependent on threonine content.

Kim J, Choi H Br J Dermatol. 2021; 186(3):532-543.

PMID: 34545566 PMC: 9299140. DOI: 10.1111/bjd.20761.

Chemical and biochemical control of skin pigmentation with special emphasis on mixed melanogenesis.

Wakamatsu K, Zippin J, Ito S Pigment Cell Melanoma Res. 2021; 34(4):730-747.

PMID: 33751833 PMC: 8861806. DOI: 10.1111/pcmr.12970.

Site-Specific Bioconjugation through Enzyme-Catalyzed Tyrosine-Cysteine Bond Formation.

Lobba M, Fellmann C, Marmelstein A, Maza J, Kissman E, Robinson S ACS Cent Sci. 2020; 6(9):1564-1571.

PMID: 32999931 PMC: 7517114. DOI: 10.1021/acscentsci.0c00940.

References

LERNER A, Fitzpatrick T, CALKINS E, SUMMERSON W . Mammalian tyrosinase; the relationship of copper to enzymatic activity. J Biol Chem. 1950; 187(2):793-802. View

Hansson C, AGRUP G, Rorsman H, ROSENGREN A, ROSENGREN E, Edholm L . Analysis of cysteinyldopas, dopa, dopamine, noradrenaline and adrenaline in serum and urine using high-performance liquid chromatography and electrochemical detection. J Chromatogr. 1979; 162(1):7-22. DOI: 10.1016/s0378-4347(00)82058-7. View

Seiji M, Yoshida T, Itakura H, IRIMAJIRI T . Inhibition of melanin formation by sulfhydryl compounds. J Invest Dermatol. 1969; 52(3):280-6. View

Hansson C, Rorsman H, ROSENGREN E . 5-hydroxydopa, a new compound in the Raper-Mason scheme of melanogenesis. Acta Derm Venereol. 1980; 60(4):281-6. View

Saetre R, Rabenstein D . Determination of cysteine in plasma and urine and homocysteine in plasma by high-pressure liquid chromatography. Anal Biochem. 1978; 90(2):684-92. DOI: 10.1016/0003-2697(78)90161-6. View

AGRUP G, Falck B, Kennedy B, Rorsman H, ROSENGREN A, ROSENGREN E . Formation of cysteinyldopa from glutathionedopa in melanoma. Acta Derm Venereol. 1975; 55(1):1-3. View

Rorsman H, ROSENGREN A, ROSENGREN E . Determination of 5-S-cysteinyldopa in melanomas with a fluorimetric method. Yale J Biol Med. 1973; 46(5):516-22. PMC: 2592004. View

Ito S, Nicol J . A new amino acid, 3-(2,5-SS-dicysteinyl-3,4-dihydroxyphenyl)alanine, from the tapetum lucidum of the gar (Lepisosteidae) and its enzymic synthesis. Biochem J. 1977; 161(3):499-507. PMC: 1164534. DOI: 10.1042/bj1610499. View

Prota G, Crescenzi S, Misuraca G, Nicolaus R . New intermediates in phaemelanogenesis in vitro. Experientia. 1970; 26(10):1058-9. DOI: 10.1007/BF02112669. View

10.

Ito S, Novellino E, Chioccara F, Misuraca G, Prota G . Co-polymerization of dopa and cysteinyldopa in melanogenesis in vitro. Experientia. 1980; 36(7):822-3. DOI: 10.1007/BF01978591. View

11.

Prota G, Rorsman H, ROSENGREN A, ROSENGREN E . Phaeomelanic pigments from a human melanoma. Experientia. 1976; 32(8):970-1. DOI: 10.1007/BF01933916. View

12.

HALPRIN K, Ohkawara A . Glutathione and human pigmentation. Arch Dermatol. 1966; 94(3):355-7. View

13.

Frenk E, Pathak M, Szabo G, Fitzpatrick T . Selective action of mercaptoethylamines on melanocytes in mammalian skin: experimental depigmentation. Arch Dermatol. 1968; 97(4):465-77. View

14.

Prota G . Recent advances in the chemistry of melanogenesis in mammals. J Invest Dermatol. 1980; 75(1):122-7. DOI: 10.1111/1523-1747.ep12521344. View

15.

Ito S, Prota G . A facile one-step synthesis of cysteinyldopas using mushroom tyrosinase. Experientia. 1977; 33(8):1118-9. DOI: 10.1007/BF01946005. View

16.

AGRUP G, Falck B, Rorsman H, ROSENGREN A, ROSENGREN E . Glutathionedopa in malignant melanoma. Acta Derm Venereol. 1977; 57(3):221-2. View

17.

Hansson C, Rorsman H, ROSENGREN E . 5-S-cysteinyldopa as a substrate for tyrosinase. Acta Derm Venereol. 1980; 60(5):399-402. View